SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001664710-23-000030
Filing Date
2023-05-04
Accepted
2023-05-04 16:04:33
Documents
54
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kros-20230331.htm   iXBRL 10-Q 1108236
2 EX-10.1 exhibit10110-qxq12023.htm EX-10.1 52801
3 EX-10.2 exhibit10210-qxq12023.htm EX-10.2 14030
4 EX-31.1 exhibit311q12023.htm EX-31.1 17332
5 EX-31.2 exhibit312q12023.htm EX-31.2 17213
6 EX-32.1 exhibit321q12023.htm EX-32.1 9945
  Complete submission text file 0001664710-23-000030.txt   4023957

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kros-20230331.xsd EX-101.SCH 26257
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kros-20230331_cal.xml EX-101.CAL 47004
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kros-20230331_def.xml EX-101.DEF 90692
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kros-20230331_lab.xml EX-101.LAB 350720
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kros-20230331_pre.xml EX-101.PRE 217488
48 EXTRACTED XBRL INSTANCE DOCUMENT kros-20230331_htm.xml XML 402300
Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

IRS No.: 811173868 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39264 | Film No.: 23888550
SIC: 2834 Pharmaceutical Preparations